- Home
- NXG vs HRTX Comparison
NXG vs HRTX Comparison
Compare NXG & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NXG | HRTX |
|---|---|---|
| Founded | 2012 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 310.4M | 265.9M |
| IPO Year | N/A | 2007 |
Fundamental Metrics
Financial Performance| Metric | NXG | HRTX |
|---|---|---|
| Price | $56.40 | $0.77 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $4.50 |
| AVG Volume (30 Days) | 42.1K | ★ 2.0M |
| Earning Date | 01-01-0001 | 05-05-2026 |
| Dividend Yield | ★ 14.78% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $154,904,000.00 |
| Revenue This Year | N/A | $15.28 |
| Revenue Next Year | N/A | $20.29 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 7.36 |
| 52 Week Low | $35.22 | $0.80 |
| 52 Week High | $56.90 | $2.61 |
Technical Indicators
Market Signals| Indicator | NXG | HRTX |
|---|---|---|
| Relative Strength Index (RSI) | 57.69 | 21.83 |
| Support Level | $46.24 | N/A |
| Resistance Level | N/A | $1.41 |
| Average True Range (ATR) | 1.47 | 0.07 |
| MACD | 0.15 | -0.02 |
| Stochastic Oscillator | 70.13 | 0.65 |
Price Performance
Historical ComparisonAbout NXG NXG NextGen Infrastructure Income Fund of Beneficial Interest
Cushing NextGen Infrastructure Income Fund is a closed-end management investment company. Its investment objective is to seek a high total return with an emphasis on current income. The fund invests at least 80% of its net assets in a portfolio of equity and debt securities of infrastructure companies, including energy infrastructure companies, industrial infrastructure companies, sustainable infrastructure companies and technology and communication infrastructure companies.
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.